Neoantigen vaccine: an emerging tumor immunotherapy

Peng Miao(Chinese Academy of Sciences), Zhaoyang Zeng(Shenzhen Academy of Robotics), Can Guo(Ministry of Agriculture), Yongzhen Mo(Central South University), Guiyuan Li(Xuzhou Medical College), Yong Li(Baylor College of Medicine), Xiaoling Li(University of Science and Technology of China), Yijie Zhang(Qingdao University), Wei Xiong(Central South University), Pan Wu(Central South University), Fang Xiong(Central South University), Yian Wang(Hunan Normal University), Steven Wu(Central South University)
Molecular Cancer
August 23, 2019
10.1186/s12943-019-1055-6
Cited by 718

Related Papers

TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619